Clinical Study to Evaluate the Effects of Disulfiram in Patients With Moderate COVID-19

PHASE2CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

November 20, 2020

Primary Completion Date

September 10, 2021

Study Completion Date

September 25, 2021

Conditions
Covid19
Interventions
DRUG

Disulfiram

The subject will receive 500 mg of disulfiram orally or enterally through NG tube if in mechanical ventilation once daily for 14 days

DRUG

Placebo

The subject will receive a matching placebo orally or enterally through NG tube if in mechanical ventilation once daily for 14 days

Trial Locations (1)

CEP 41830-492

ETICA, Salvador

All Listed Sponsors
collaborator

Spring Research Foundation

NETWORK

lead

ETICA

OTHER

NCT04594343 - Clinical Study to Evaluate the Effects of Disulfiram in Patients With Moderate COVID-19 | Biotech Hunter | Biotech Hunter